Advisors Capital Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Advisors Capital Management's CLB Position: Q2 2026 in Review
Advisors Capital Management reduced its Core Laboratories (CLB) stake by 18% in Q2 2026, selling an estimated $731K and leaving 237,398 shares worth $2.77M. The position accounts for 0.03% of the portfolio, ranked #269.
Advisors Capital Management first reported a position in CLB in Q1 2019 and has held it in 17 quarters since. The position peaked at $5.53M in Q3 2023. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Advisors Capital Management held 237,398 shares of Core Laboratories worth $2.77M as of Q2 2026.
- Advisors Capital Management sold 51,232 Core Laboratories shares in Q2 2026, an estimated $731K.
- Core Laboratories made up 0.03% of Advisors Capital Management's portfolio in Q2 2026, its #269 holding.
- Advisors Capital Management first reported a position in Core Laboratories in Q1 2019 and has held it in 17 quarters since.
- Advisors Capital Management's Core Laboratories position peaked at $5.53M in Q3 2023.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Advisors Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.